Huiya Wu, a partner in Goodwin's IP Litigation practice, is a member of the firm’s Life Sciences Disputes group and is an intellectual property litigator who has spent more than 20 years litigating and trying cases in both federal and state courts, and has appeared before the Patent and Trademark Office (PTO), the Patent Trial and Appeal Board (PTAB), as well as the International Trade Commission (ITC). She has represented clients in a wide range of technologies, including pharmaceuticals, analytical devices, medical devices, automotive parts, and internet business methods, and has particular expertise in litigation under the Hatch-Waxman Act and the Biologics Price Competition and Innovation Act. 

Ms. Wu has been recognized in Intellectual Asset Management’s Patent 1000, an annual listing of the world’s leading patent practitioners, in which clients have described her as “super-clever, highly persuasive and thoughtful,” “a top-notch advocate and trusted adviser who helps you achieve your key business objectives,” and having “first-rate technical expertise and an appealing and effective courtroom presentation manner,” and “an excellent attorney who can always be trusted to put her clients’ needs first.” 

She has an active pro bono practice, including her work with the Legal Services NYC, Project Citizenship, Joyful Heart Foundation, and My Sisters’ Place, and is a recipient of the New York City Bar Association’s Thurgood Marshall Award for her work defending individuals in capital punishment cases. She also currently serves as co-chair of Goodwin’s Women’s Initiative.





Highlights of Ms. Wu’s work includes representing:

  • Amneal Pharmaceuticals, in currently pending patent infringement cases, one involving a generic formulation of vasopressin injection, and another involving a generic formulation of dimethyl fumarate. Par Pharmaceutical et al. v. Amneal et al. (D. Del.); Biogen v. Amneal et al. (D. Del.)
  • Fresenius Kabi, in an inter partes review proceeding involving a patent on purification processes for proteins expressed in non-mammalian systems. Fresenius Kabi et al. v. Amgen et al. (PTAB)
  • Celltrion, in parallel BPCIA patent infringement and inter partes review proceedings involving Celltrion’s biosimilar to Rituxan. Genentech v. Celltrion (D.N.J./PTAB)
  • Sun Pharmaceutical, as lead counsel at trial in a patent infringement case involving a generic drug product to treat rosacea. Case settled favorably. Galderma et al. v. Sun Pharmaceutical et al. (D. Del.)
  • Taro Pharmaceuticals, as lead counsel in parallel patent infringement and inter partes review proceedings involving a generic drug product used to treat iron overload caused by blood transfusions. Case settled favorably after expert discovery. ApoPharma et al. v. Taro Pharmaceuticals et al. (E.D. Tex./PTAB)
  • Torrent Pharmaceuticals, in a successful challenge before the PTAB, in filing an inter partes review petition on an Orange-Book-listed patent relating to formulations for treating multiple sclerosis. Torrent Pharmaceuticals et al. v. Novartis et al. (PTAB)
  • Glenmark Pharmaceuticals, as second-chair counsel at trial and appeal in a patent infringement case involving a generic gel drug product to treat rosacea. Intendis GmbH et al. v. Glenmark Pharmaceuticals et al. (D. Del.)
  • Cipla, as lead counsel in a patent infringement case involving eye drops to treat ocular itching associated with allergies. Case settled favorably. Alcon Research et al. v. Cipla Limited et al. (S.D. Ind.)
  • Tris Pharma, in a trade secret case involving a prescription cough syrup, in which the court denied UCB’s motion for a preliminary injunction and subsequently granted summary judgment in favor of Tris Pharma on UCB’s trade secret claims. UCB Manufacturing v. Tris Pharma et al. (New Jersey state court)
  • Robert Bosch in a patent infringement case before the ITC related to windshield wipers, which settled favorably. In the Matter of Certain Wiper Blades (ITC)
  • Boston Scientific at trial and on appeal in a patent infringement case related to stents, which settled favorably. Cordis Corp. v. Boston Scientific Corp. et al. (D. Del.)
  • Applied Biosystems at trial and on appeal in a patent infringement case related to mass spectrometers. The Federal Circuit affirmed jury verdict of $47.5 million, the fourth-largest jury verdict in an intellectual property case that year. Applied Biosystems et al. v. Micromass UK Ltd. et al. (D. Del.)
Professional Activities

Ms. Wu is a member of the New York State Bar Association, the New York Intellectual Property Law Association, and the American Intellectual Property Law Association.

Professional Experience

Prior to joining Goodwin in 2014, Ms. Wu was a partner at Kenyon & Kenyon in New York City, where she was a member of that firm’s Associates Committee and Diversity Committee. She currently serves on the Women@Goodwin Committee, which actively supports the firm's goals to attract, retain, develop and advance women at all stages of their careers. She participated on Goodwin’s behalf in the inaugural Women in Law Hackathon, a competition aimed at generating new ideas to address the gender disparity in the legal industry. Ms. Wu has spoken at numerous legal seminars and appeared on panel presentations sponsored by various organizations, both in the U.S. and internationally.


Ms. Wu has been recognized by Patexia’s Top ANDA Litigators in 2020 list. 

Ms. Wu was named by IAM Patent 1000The World’s Leading Patent Professionals as one of the world’s leading patent litigators, 2016 - 2020.

In The News









JD, 1999
The George Washington University Law School
BS, Chemical Engineering, 1996
University of Massachusetts Amherst

(cum laude)

BA, Chemistry, 1996
University of Massachusetts Amherst



New York
U.S. Patent and Trademark Office (USPTO)


U.S. District Court for the Eastern District of New York
U.S. District Court for the Southern District of New York
U.S. Court of Appeals for the Federal Circuit





Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique